Importantly, NF-κB activation—particularly when potentiated by SUMOylation or specific lysine acetylation events—directly upregulates PD-L1 expression on both tumor and immune cells, diminishing T cell cytotoxicity and contributing to immune checkpoint blockade resistance (27). This evidence concerns the gene NFKB1 and neoplasm.